Migrasome Therapeutics

China
Chongqing, Chongqing, China

Company profile

Migrasome Therapeutics company profile

Migrasome Therapeutics is an innovative drug research and development company based on new biological discoveries.

Business identity

Operating status
Active
Company type
For Profit
Founded
2022-04-01, Month

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$14M
Last funding
Angel / $14M / 2023-07-26
Last equity funding
Angel / $14M
Investors
4
Lead investors
1

Founders and investors

Lead investors

Zhongguancun Collaborative Innovation Fund

Investors

Beijing Capital Science and Technology Development GroupTsinghua CapitalZGC GroupZhongguancun Collaborative Innovation Fund